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Human milk bile salt-stimulated lipase ensures efficient triacylglycerol utilization m breast-fed newborns. For activity against long-chain triacyl- 
glycerol, primary bile salts are a prerequistte. Btle salts also protect the enzyme from inactivation by Intestinal proteases. We have studied the effect 
of different bile salts on activation, protease protection, lipid binding, and enzyme inactivation, caused by an arginine modifying agent. Based on 
the results we propose a model involving two bile salt binding sites; one activation-site specific for primary bile salt, and another, less specific, lipid 
binding promoting site at which also secondary bile salt binds. Binding to this latter site induces binding of enzyme to emulsified substrates but 
without subsequent lipolysts. 
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1. INTRODUCTION 
The bile salt-stimulated lipase, a constituent of 
human milk, has a recognized function in milk lipid 
digestion in the breast-fed infant [1,2]. Cloning and se- 
quencing of the respective cDNA from human mam- 
mary gland and pancreas has shown that the peptide 
chain of the milk enzyme is identical to that of the 
carboxyl ester hydrolase secreted from the pancreas [3- 
5]. There may, however, be minor molecular differ- 
ences, presumably with regard to glycosylation, re- 
vealed by a slight difference in molecular size [6]. 
Bile salts have several effects on the enzyme(s). Acti- 
vation against emulsified triacylglycerol or cholesteryl 
ester is achieved exclusively with primary bile salts, i.e. 
bile salt containing the 7a-hydroxyl group [7,8]. For 
activity against other substrates, e.g. p-nitrophenyl ace- 
tate, such activation is not required, although enhanced 
activity is obtained with various bile salts [7-91 but also 
other detergents [lo]. For the milk enzyme it has been 
shown that protection against intestinal proteolysis is 
obtained by primary as well as secondary bile salts [l 11. 
Kinetics of the bile salt effect has been studied using 
different substrates [7,9,10,12,13]. Models for the inter- 
action of the milk enzyme with different substrates have 
also been proposed [14,15]. As yet, however, the mech- 
anism of activation is largely unknown. Wang and Lee 
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suggested that activation is caused merely by bile salt- 
induced binding of the enzyme to the emulsion particle 
surface [13]. For the pancreatic enzyme Lombard0 et al. 
[16] have proposed a model according to which the 
peptide chain has two different bile salt binding sites; 
one that is non-specific as to type of bile salt and an- 
other that is specific for primary bile salts. They give 
evidence that primary, but not secondary bile salt, cause 
dimerization of the enzyme [I 71, presumably via interac- 
tion at the second site. Their model does not include any 
suggestions as to how the catalytical efficiency is af- 
fected by interaction at the different binding sites. The 
present study shows that activation of the milk enzyme 
cannot be fully explained by either of these two pro- 
posed mechanisms. 
2. MATERIALS AND METHODS 
Bile salt-stimulated lipase was purified from human milk as de- 
scribed [18]. Sodium taurocholate was prepared by Dr L. Krabisch. 
Lund. Sweden. Sodium taurodeoxycholate, gum arabic. bovme serum 
albumin and butanedione (diacetyl) were from Sigma Chemical Co., 
St. Louis. MO, USA, and cholamidopropyl dimethylammonio 
propanesulphate (CHAPS) from Pierce Chemical Co, Rockford. IL, 
USA. Bovine trypsin (Trypsin TPCK) was from Worthington Dtag- 
nostic Systems Inc., Freehold, NJ, USA. 
Lipase activity was determined as previously described using long- 
cham triacylglycerol emulsified m gum arabic as substrate [IQ. 
2.1. Bindmg to lipid emulsion 
Purified bile salt-stimulated lipase was labeled with ‘25I by the lac- 
toperoxidase/glucosoxidase method [19]. Iodination 
lipase was added to 
4.5 ml of a mixture of 0.1 M NaCl. 40 mM Tris-Cl 
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contained an emulsion of 2 mg long-chain triacylglycerol in gum 
arabic and 9 mg bovine serum albumin per ml. After 15 min incuba- 
tion at 20°C this mixture was transferred to ultracentrifuge tubes 
(13 x 51 mm, Beckman Instruments, Palo Alto, CA, USA). After 
centrifugation at 60,000 x g for 20 min the tubes were sliced below the 
fatty top phase This phase. as well as the aqueous sub-phase. was 
collected, the radioactivity counted and used as an estimate of the 
amount of enzyme present in the respective phase. 
2 2. Agarose gel electrophorem 
15 ml of agarose solution, 1% (w/v) in 0.05 M sodium barbital 
buffer. pH 8.5, was poured onto glass plates (83.5 x 93.5 mm’). Wells 
( 1 x 7 mm’) were punched 1 cm from the cathodal end. Samples (lo-15 
fll with a protein concentration of approximately 0.5 mg/ml) were 
applied and electrophoresis run for 2 h on a Multlphore (LKB. Swe- 
den) at 4°C with a current of 4 V/cm. Bovine serum albumin and 
transferrin were included as references in all runs. 0 05 M sodium 
barbital, pH 8.5, was used as electrode buffer. When electrophoresis 
was run in the presence of bile salts these were included, at the concen- 
trations given m Table I, in the cathode buffer as well as in the agarose 
solution. CHAPS was added only to the agarose solution. Protein was 
fixed with saturated picric acid in 15% acetic acid prior to pressing and 
drying of the plates. Proteins were stained with Coomassie brilliant 
blue. 
3. RESULTS AND DISCUSSION 
To explore the underlying structural requirements of 
a bile salt, or analogue, for various effects ascribed to 
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Fig. 1 Structures of the bile salts and bile salt analogue used in the 
present study: 2-[(3a,7a, 12a-trihydroxy-24-oxo-5~-cholan-24-y1)- 
aminolethane sulfonate (taurocholate), 2-[(3a.l2a-dihydroxy-24-oxo- 
5B-cholan-24-yl)amino]ethane sulfonate (taurodeoxycholate), and 
3a,7a,l2a-trihydroxy-24-cholanamidopropyl dimethylammonio pro- 
panesulphate (CHAPS). 
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Fig. 2. Sensitivity of bile salt-stimulated lipase to inactivation by tryp- 
sin m the presence of bile salt or CHAPS. Purlfied bile salt-stimulated 
hpase was incubated with lo-fold molar excess of trypsm in 5 mM 
sodium barbital buffer, pH 7.4, contammg 0.05 M NaCl. Taurocho- 
late (TC), taurodeoxycholate (TDC) or CHAPS were included at the 
concentrations indicated. After 30 mm incubation at 37°C aliquots 
were withdrawn and the remaining enzyme activity determined. Val- 
ues are expressed as percent of parallel Incubations in absence of 
trypsin. 
bile salts we chose the following: cholate, which con- 
tains three hydroxyl groups (3a, 7a, 12a) and is classi- 
fied as a primary bile salt; deoxycholate, which lacks the 
7ol-hydroxyl group and is classified as a secondary bile 
salt; and CHAPS. which is not classified as a bile salt 
but has an identical steroid backbone to cholate, includ- 
ing the 301,7a, 1% hydroxyl groups. For detailed struc- 
tures see Fig. 1. In duodenal contents the major part of 
the bile salts are present as conjugates with taurine or 
glycine. CHAPS differs by having a permanent side 
chain of different structure. Thus, while the bile salts, 
conjugated or not, are negatively charged CHAPS has 
no net charge. Previously we have found that primary 
bile salts are a prerequisite for activity of bile salt-stim- 
ulated lipase with long-chain triacylglycerol, including 
those of human milk, as substrate [6,7,20]. Since conju- 
gated, as well as non-conjugated cholate, is effective it 
is evident that the side chain is dispensable with regard 
to activation, however, since CHAPS was unable to 
activate the enzyme (data not shown) it is obvious that 
a structurally different side chain can interfere with the 
activation mechanism. 
Another previously recognized physiologically im- 
portant function of bile salts is to protect the enzyme 
from inactivation by trypsin and other proteolytic en- 
zymes present in intestinal contents [I 1,211. In contrast 
to activation. both types of bile salts, as well as CHAPS, 
have a protective effect (Fig. 2). This might suggest that 
protection is due to a non-specific detergent effect, but 
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Fig. 3. Effect of bile salts and CHAPS on the binding of bile salt- 
stimulated lipase to a lipid emulston. Purified and ?-labeled bile 
salt-stimulated lipase was incubated with a lipid emulsion as descrtbed 
in section 2. Taurocholate (TC), taurodeoxycholate (TDC) or CHAPS 
were included at the concentrations given. The fatty top phase and 
aqueous sub-phase were recovered by centrifugation and then radio- 
activity counted. 
Triton X-100, a potent detergent with completely dif- 
ferent structure, caused no protection (data not 
shown). 
Except for the requirement of primary bile salts the 
molecular events behind activation are unknown. Re- 
cently it was shown that taurocholate increased the 
binding of enzyme to a lipid-water interface, and this 
was proposed as the essential event in activation [17]. 
Therefore we studied whether bile salt-induced binding 
had the same specificity as activation. 
Taurodeoxycholate, which does not activate, was at 
least as effective as taurocholate in binding the enzyme 
to emulsion particles (Fig. 3). At a 5 mM concentration, 
which is above that required for activity, about 70% of 
the enzyme was bound both with taurocholate and tau- 
rodeoxycholate. In contrast, CHAPS, irrespective of 
concentration, did not induce binding, demonstrating 
that the side chain, possibly due to its lack of net charge, 
had a decisive effect. From these results it is evident that 
the activation mechanism is more complex than previ- 
Table I 
Charge-shift electrophoresis of bile salt-stimulated lipase 
Addition Relative migration 
None 1 .oo 
5 mM taurocholate 1.37 
5 mM taurodeoxycholate 1.69 
5 mM taurocholate and 5 mM CHAPS 1.19 
5 mM taurodeoxycholate and 5 mM CHAPS 1.72 
ously suggested. Primary as well as secondary bile salts 
affected the mobility of purified lipase in charge-shift 
electrophoresis (Table I), demonstrating that both bile 
salts bind to the enzyme. This is in concert with previous 
studies with immobilized bile salt [22]. That the lipase 
is affected by primary as well as secondary bile salts is 
further supported by similar spectral changes observed 
for both types of bile salt when studied by fluorescence 
spectroscopy [23]. 
Since CHAPS did not induce binding to emulsion 
particles (Fig. 3) one would expect no interference of 
CHAPS with binding between enzyme and the two bile 
salts. Because CHAPS is devoid of a net charge this 
could be tested by use of charge-shift electrophoresis. 
Interestingly, binding of deoxycholate was unaffected 
while that of cholate was significantly reduced (Table I). 
This observation would be compatible with two binding 
sites for bile salts, one that is less specific and mediated 
via charge and another that is specifically dependent on 
the 7a-hydroxyl group of primary bile salts at which 
CHAPS competes. 
Further studies of the interaction of bile salts with the 
enzyme protein were carried out by use of butanedione. 
This amino acid modifying agent binds covalently to 
arginine residues. When enzyme was mixed with buta- 
nedione, activity was lost in a time- and dose-dependent 
manner (data not shown). This is in agreement with 
observations made with carboxylic ester hydrolase [ 161, 
the pancreatic counterpart of the milk enzyme [3,5]. 
Amino acid analysis revealed that, at the highest con- 
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Fig. 4. Effect of bile salt and CHAPS on the inhibition of lipase activity 
by butanedione. Purified bile salt-stimulated lipase was incubated at 
37°C in 10 mM butanedione in 0.1 M sodium borate buffer, pH 8.5. 
Prior to the addition of butanedione taurocholate (TC), taurode- 
oxycholate (TDC) or CHAPS were added to the concentrations indi- 
cated. After 30 min incubation aliquots were withdrawn and their 
enzyme activity assayed. Values are expressed as percent of a control 
incubated in parallel in the absence of butanedione. 
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Fig. 5. Schematic presentatton of the tentative bile salt binding sites 
on bile salt-stimulated lipase. The proposed nature of the bindmg to 
the respective sites are indicated by H for hydrogen bonding and by 
+ for charge-dependent interaction The potential ligands, used m this 
study, to the sites are indicated 
centration used, about two thirds of the arginine resi- 
dues were modified (data not shown). If the enzyme was 
mixed with bile salts prior to incubation with butanedi- 
one the results were different. Increasing concentrations 
of cholate. or of deoxycholate, led to a protection (Fig. 
4) i.e. the higher the bile salt concentration the more 
enzyme activity was retained up to a maximum of 80% 
at 2 mM bile salt. These data strongly suggest that 
arginine residue(s) are involved in bile salt binding. 
That CHAPS did not have a protective effect (Fig. 4) 
implies that this binding is dependent on the charge of 
the side chain of the ligand. 
From the presented data a tentative model for the bile 
salt interaction with bile salt-stimulated lipase can be 
drawn (Fig. 5). Bile salt interacts with at least two sites 
on the enzyme protein. The first site is less specific and 
may be designated the ‘lipid binding promoting site’. At 
this site one or several arginine residues on the enzyme 
interact with negatively charged side chains of bile salts, 
regardless of the hydroxylation pattern of the back- 
bone. Hence. both primary and secondary bile salts are 
potential ligands to this site. Binding of bile salt to this 
site is a prerequisite for binding of the enzyme to a 
triacylglycerol emulsion surface. In contrast to previous 
suggestions [13]. however, merely binding does not 
cause activation. If it did, there should be no obligatory 
requirement for primary bile salts for activation. Thus, 
a second site must be present which is specific for bile 
salts containing a 7a-hydroxyl group. This is evident 
from the fact that deoxycholate, differing from cholate 
only by its lack of a 7a-hydroxyl group (Fig. l), is 
unable to activate the enzyme. Most reasonably, inter- 
action at this site occurs specifically via this hydroxyl 
group. 
This model is compatible with our previous observa- 
tion that the presence of secondary bile salt (taurode- 
oxycholate) reduces the concentration of primary bile 
salt (taurocholate) needed for activation [21]. Two bind- 
ing sites with different specificity is also in agreement 
with what has been proposed for carboxylic ester hydro- 
lase [16]. For this enzyme binding at the specific site 
causes dimerization of the enzyme which is considered 
as the essential step in activation. This does not occur 
with bile salt-stimulated lipase (unpublished observa- 
tion). A specific conformational change induced by 
binding of primary bile salt seems a likely prerequisite 
but needs to be verified. 
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